Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cecilia Isaksson
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse
JAMA Oncology
Cancer Research
Oncology
Allogeneic Stem Cell Transplantation for Acquired Pure Red Cell Aplasia
American Journal of Hematology
Hematology
Related publications
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse After Transplant
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
No Association Between Donor Telomere Length and Outcomes After Allogeneic Unrelated Hematopoietic Cell Transplant in Patients With Acute Leukemia
Bone Marrow Transplantation
Transplantation
Hematology
Donor Lymphocyte Experience in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Sezary Syndrome in Relapse After Reduced Intensity Allogeneic Transplant Successfully Treated With Donor Lymphocyte Infusion
Bone Marrow Transplantation
Transplantation
Hematology
Extramedullary Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Treatment of Relapsed Acute Myeloid Leukemia With MLL/AF6 Fusion After Allogeneic Hematopoietic Stem Cell Transplantation With Gemtuzumab Ozogamicin With a Long Interval Followed by Donor Lymphocyte Infusion
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Donor Lymphocyte Infusion Induced Molecular Remission in Relapse of Acute Myeloid Leukaemia After Allogeneic Bone Marrow Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Prognosis of Patients With a Second Relapse of Acute Myeloid Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Increased Immune Suppression Is Associated With Worse Overall Survival in Allogeneic Hematopoietic Cell Transplant Patients Receiving Reduced Intensity Continuous Infusion Busulfan
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
